{"text": ["AbbVie", "Rises", "3%"], "created_at": "2019-05-14 14:43:03"}
{"text": ["MC10,", "Inc.", "and", "AbbVie", "(NYSE:ABBV)", "Announce", "Clinical", "Trials", "in", "Multiple", "Sclerosis", "Using", "the", "BioStamp", "nPoint\u00ae\u00a0System"], "created_at": "2019-05-14 14:13:00"}
{"text": ["Here", "are", "the", "stocks", "to", "buy", "if", "an", "all-out", "U.S.-China", "trade", "war", "erupts,", "says", "Goldman"], "created_at": "2019-05-14 14:07:00"}
{"text": ["AbbVie", "stock", "up", "1.3%", "after", "announcing", "resolution", "to", "litigation", "over", "Humira", "in", "the", "U.S."], "created_at": "2019-05-14 12:57:00"}
{"text": ["AbbVie", "Resolves", "HUMIRA\u00ae", "(adalimumab)", "U.S.", "Patent", "Litigation", "with", "Boehringer", "Ingelheim"], "created_at": "2019-05-14 12:34:00"}
{"text": ["AbbVie", "to", "Present", "at", "the", "UBS", "Global", "Healthcare", "Conference"], "created_at": "2019-05-14 12:00:00"}
